UK Companies House feature
GAMA HEALTHCARE CORPORATION LIMITED
Cash
—
Latest balance sheet
Net assets
£895K
-8.6% vs 2024
Employees
205
-25.5% vs 2024
Profit before tax
—
Period ending 2025-03-31
Profile
- Company number
- 10759004
- Status
- Active
- Incorporation
- 2017-05-08
- Last accounts made up
- 2025-03-31
- Account category
- GROUP
- Primary SIC
- 32500
- Hubs
- UK Healthcare
Net assets
5-year trend · vs UK Healthcare median
Accounts
5-year trend · latest 2025-03-31
| Metric | Trend | 2022-04-01 | 2023-03-31 | 2023-04-01 | 2024-03-31 | 2025-03-31 |
|---|---|---|---|---|---|---|
| Turnover | — | — | — | — | — | |
| Operating profit | — | — | — | — | — | |
| Profit before tax | — | — | — | — | — | |
| Net profit | — | -£33,133 | — | -£44,922 | -£53,953 | |
| Cash | — | — | — | — | — | |
| Total assets less current liabilities | — | £1,073,985 | — | £979,063 | £895,110 | |
| Net assets | — | £1,073,985 | — | £979,063 | £895,110 | |
| Equity | £1,107,118 | £1,073,985 | £1,073,985 | £979,063 | £895,110 | |
| Average employees | — | 352 | — | 275 | 205 | |
| Wages | — | — | — | — | — |
Values shown as filed in iXBRL accounts. — indicates the figure was not present in the extracted filing (either not filed under that concept or absent from the period). About these numbers
Audit & accounting basis
From AI-extracted PDF accounts
- Accounting basis
- FRS 102
- Reporting scope
- Consolidated (group)
- Auditor
- Barnes Roffe Audit Limited
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The directors note that the group and company are trading adequately and have sufficient working capital and other finance available to continue for a period of not less than 12 months from the date of approval of these financial statements. As such the directors believe that there are no significant uncertainties in their assessment of whether the business is a going concern and therefore have prepared the accounts on a going concern basis.”
Subsidiaries
- GAMA Healthcare Limited · 100% held · England · Promotion and sale of medical products
- GAMA Healthcare (Foshan) Limited · 100% held · China · Promotion and sale of medical products
- Carell Limited · 100% held · England · Dormant
- GAMA Corporation Pty Limited · 100% held · Australia · Holding company
- GAMA Healthcare Pty Limited · 100% held · Australia · Promotion and sale of medical products (subsidiary of GAMA Corporation Pty Limited)
Significant events
- “On 21 May 2024, the company granted options to purchase 245,902 of Ordinary C shares at a subscription price of 1p per share.”
Auditor / going-concern / subsidiary information is extracted from the PDF version of the latest annual accounts and is not tagged in iXBRL. About these numbers
People
3 active · 0 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| BRAVERMAN, Guy, Dr | Director | 2017-05-08 | May 1979 | British |
| HANOUKA, Allen, Dr | Director | 2017-08-01 | Jan 1974 | British |
| SCHRETTER, Al | Director | 2025-11-18 | Jun 1966 | American |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Deb Holdings Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2025-11-18 | Active |
| Mr Guy Braverman | Individual | Shares 25–50%, Voting 25–50% | 2022-05-05 | Ceased 2025-11-18 |
| Dr Allen Hanouka | Individual | Shares 25–50%, Voting 25–50% | 2022-05-05 | Ceased 2025-11-18 |
| Gama Investment Group Ltd | Corporate entity | Shares 25–50%, Voting 25–50% | 2022-01-17 | Ceased 2025-11-18 |
| Gama Investment Group Limited | Corporate entity | Shares 25–50%, Voting 25–50% | 2022-01-17 | Ceased 2022-05-05 |
| Dr Allen Hanouka | Individual | Shares 25–50%, Voting 25–50% | 2017-08-01 | Ceased 2022-01-17 |
| Dr Guy Braverman | Individual | Shares 25–50%, Voting 25–50% | 2017-05-08 | Ceased 2022-01-17 |
Filing timeline
Last 20 of 60 total filings
| Date | Type | Category | Description |
|---|---|---|---|
| 2025-11-28 | RESOLUTIONS | resolution | resolution |
| 2025-11-20 | PSC02 | persons-with-significant-control | notification of a person with significant control |
| 2025-11-20 | AP01 | officers | appoint person director company with name date |
| 2025-11-19 | PSC07 | persons-with-significant-control | cessation of a person with significant control |
| 2025-11-19 | PSC07 | persons-with-significant-control | cessation of a person with significant control |
| 2025-11-19 | PSC07 | persons-with-significant-control | cessation of a person with significant control |
| 2025-11-17 | SH01 | capital | capital allotment shares |
| 2025-09-18 | AA | accounts | accounts with accounts type group |
| 2025-08-07 | PSC04 | persons-with-significant-control | change to a person with significant control |
| 2025-08-07 | CH01 | officers | change person director company with change date |
| 2025-05-01 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2024-12-11 | AA | accounts | accounts with accounts type group |
| 2024-04-30 | CS01 | confirmation-statement | confirmation statement with updates |
| 2024-02-12 | MA | incorporation | memorandum articles |
| 2024-02-07 | RESOLUTIONS | resolution | resolution |
| 2024-01-19 | SH02 | capital | capital alter shares subdivision |
| 2024-01-19 | MA | incorporation | memorandum articles |
| 2024-01-19 | SH08 | capital | capital name of class of shares |
| 2024-01-19 | RESOLUTIONS | resolution | resolution |
| 2023-12-31 | AA | accounts | accounts with accounts type group |
Credit score
Altman Z″ — composite of working capital, retained earnings, EBIT, and leverage
Activity Score
Composite activity score · components 0–100 · reference 2026-05-10
40.7
COOL
/ 100
- Filings velocity 83
- Capital events 20
- Officer churn 25
- Headcount trajectory 25
- Accounts trajectory 41
- 10 filing(s) in last 12 months
- 1 capital event(s) in last 24 months
- 1 appointed, 0 resigned (12mo)
- Employees -25% YoY
- Net Assets -9% YoY